Protagonist Therapeutics, Inc Capital Expenditures
Protagonist Therapeutics, Inc (PTGX) reported Capital Expenditures of $383.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $168.00K, a 79.34% decline year-over-year.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $215.00K, a 60.55% decline year-over-year.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $144.00K, a 53.55% decline year-over-year.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $88.00K, a 88.65% decline year-over-year.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for fiscal 2025 was $1.59M, a 17.34% increase from fiscal 2024.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for fiscal 2024 was $1.35M, a 122.50% increase from fiscal 2023.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for fiscal 2023 was $609.00K, a 23.40% decline from fiscal 2022.
- Protagonist Therapeutics, Inc payments to acquire property, plant, and equipment for fiscal 2022 was $795.00K, a 27.79% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $383.00K 10-Q · filed 2026-08-05 | $527.00K derived: sum of 3 quarters · filed 2026-08-05 | $615.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $215.00K 10-Q · filed 2026-05-05 | $359.00K derived: sum of 2 quarters · filed 2026-05-05 | $447.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.26M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $232.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.04M derived: sum of 3 quarters · filed 2026-08-05 | $1.59M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $901.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.45M 10-Q · filed 2025-11-06 | $1.76M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $813.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.36M 10-Q · filed 2026-08-05 | $1.67M derived: sum of 3 quarters · filed 2026-08-05 | $2.44M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $545.00K 10-Q · filed 2026-05-05 | $855.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.63M derived: sum of 3 quarters · filed 2026-05-05 | $1.66M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.08M derived: sum of 2 quarters · filed 2026-02-25 | $1.11M derived: sum of 3 quarters · filed 2026-02-25 | $1.35M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $803.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.04M 10-Q · filed 2025-11-06 | $1.06M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $270.00K 10-Q · filed 2025-08-06 | $289.00K derived: sum of 3 quarters · filed 2026-02-25 | $693.00K derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $242.00K 10-Q · filed 2025-05-06 | $261.00K derived: sum of 2 quarters · filed 2026-02-25 | $665.00K derived: sum of 3 quarters · filed 2026-02-25 | $841.00K derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $423.00K derived: sum of 2 quarters · filed 2026-02-25 | $599.00K derived: sum of 3 quarters · filed 2026-02-25 | $609.00K 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $580.00K derived: sum of 2 quarters · filed 2024-11-07 | $590.00K 10-Q · filed 2024-11-07 | $660.00K derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $186.00K 10-Q · filed 2024-08-06 | $256.00K derived: sum of 3 quarters · filed 2025-02-21 | $418.00K derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-07 | $80.00K derived: sum of 2 quarters · filed 2025-02-21 | $242.00K derived: sum of 3 quarters · filed 2025-02-21 | $532.00K derived: sum of 4 quarters · filed 2025-02-21 | ||
| 2022-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $232.00K derived: sum of 2 quarters · filed 2025-02-21 | $522.00K derived: sum of 3 quarters · filed 2025-02-21 | $795.00K 10-K · filed 2025-02-21 | ||
| 2022-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $452.00K derived: sum of 2 quarters · filed 2023-11-02 | $725.00K 10-Q · filed 2023-11-02 | $921.00K derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $563.00K 10-Q · filed 2023-08-03 | $759.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.02M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $273.00K 10-Q · filed 2023-05-04 | $469.00K derived: sum of 2 quarters · filed 2024-02-27 | $734.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.23M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $461.00K derived: sum of 2 quarters · filed 2024-02-27 | $961.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.10M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $765.00K derived: sum of 2 quarters · filed 2022-11-08 | $905.00K 10-Q · filed 2022-11-08 | $1.03M derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $640.00K 10-Q · filed 2022-08-04 | $765.00K derived: sum of 3 quarters · filed 2023-03-15 | $840.00K derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2021-03-31 | $140.00K 10-Q · filed 2022-05-05 | $265.00K derived: sum of 2 quarters · filed 2023-03-15 | $340.00K derived: sum of 3 quarters · filed 2023-03-15 | $473.00K derived: sum of 4 quarters · filed 2023-03-15 | ||
| 2020-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $200.00K derived: sum of 2 quarters · filed 2023-03-15 | $333.00K derived: sum of 3 quarters · filed 2023-03-15 | $471.00K 10-K · filed 2023-03-15 | ||
| 2020-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $208.00K derived: sum of 2 quarters · filed 2021-11-03 | $346.00K 10-Q · filed 2021-11-03 | $564.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $271.00K 10-Q · filed 2021-08-04 | $489.00K derived: sum of 3 quarters · filed 2022-02-28 | $180.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $138.00K 10-Q · filed 2021-05-04 | $356.00K derived: sum of 2 quarters · filed 2022-02-28 | $47.00K derived: sum of 3 quarters · filed 2022-02-28 | $939.00K derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$91.00K derived: sum of 2 quarters · filed 2022-02-28 | $801.00K derived: sum of 3 quarters · filed 2022-02-28 | $967.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | -$309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $583.00K derived: sum of 2 quarters · filed 2020-11-04 | $749.00K 10-Q · filed 2020-11-04 | $811.00K derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-06-30 | $892.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.06M 10-Q · filed 2020-08-06 | $1.12M derived: sum of 3 quarters · filed 2021-03-10 | $1.27M derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2019-03-31 | $166.00K 10-Q · filed 2020-05-07 | $228.00K derived: sum of 2 quarters · filed 2021-03-10 | $376.00K derived: sum of 3 quarters · filed 2021-03-10 | $444.00K derived: sum of 4 quarters · filed 2021-03-10 | ||
| 2018-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $210.00K derived: sum of 2 quarters · filed 2021-03-10 | $278.00K derived: sum of 3 quarters · filed 2021-03-10 | $486.00K 10-K · filed 2021-03-10 | ||
| 2018-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $216.00K derived: sum of 2 quarters · filed 2019-11-06 | $424.00K 10-Q · filed 2019-11-06 | $480.00K derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2018-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $276.00K 10-Q · filed 2019-08-07 | $332.00K derived: sum of 3 quarters · filed 2020-03-10 | $522.00K derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2018-03-31 | $208.00K 10-Q · filed 2019-05-08 | $264.00K derived: sum of 2 quarters · filed 2020-03-10 | $454.00K derived: sum of 3 quarters · filed 2020-03-10 | $826.00K derived: sum of 4 quarters · filed 2020-03-10 | ||
| 2017-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $246.00K derived: sum of 2 quarters · filed 2020-03-10 | $618.00K derived: sum of 3 quarters · filed 2020-03-10 | $666.00K 10-K · filed 2020-03-10 | ||
| 2017-09-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $562.00K derived: sum of 2 quarters · filed 2018-11-06 | $610.00K 10-Q · filed 2018-11-06 | $662.00K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $420.00K 10-Q · filed 2018-08-07 | $472.00K derived: sum of 3 quarters · filed 2019-03-12 | $488.00K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-03-31 | $48.00K 10-Q · filed 2018-05-09 | $100.00K derived: sum of 2 quarters · filed 2019-03-12 | $116.00K derived: sum of 3 quarters · filed 2019-03-12 | $144.00K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2016-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $68.00K derived: sum of 2 quarters · filed 2019-03-12 | $96.00K derived: sum of 3 quarters · filed 2019-03-12 | $347.00K 10-K · filed 2019-03-12 | $379.00K 10-K · filed 2017-03-07 | |
| 2016-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $44.00K derived: sum of 2 quarters · filed 2017-11-07 | $295.00K 10-Q · filed 2017-11-07 | $327.00K 10-Q · filed 2016-11-14 | $515.00K derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $279.00K 10-Q · filed 2017-08-08 | $499.00K derived: sum of 3 quarters · filed 2018-03-07 | $612.00K derived: sum of 4 quarters · filed 2018-03-07 | ||
| 2016-03-31 | $251.00K 10-Q · filed 2017-05-10 | $471.00K derived: sum of 2 quarters · filed 2018-03-07 | $584.00K derived: sum of 3 quarters · filed 2018-03-07 | |||
| 2015-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $333.00K derived: sum of 2 quarters · filed 2018-03-07 | $399.00K 10-K · filed 2018-03-07 | |||
| 2015-09-30 | $113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $179.00K 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $66.00K 10-Q · filed 2016-09-15 | |||||
| 2014-12-31 | $299.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |